Skip to main content
. 2015 Sep 29;14:129. doi: 10.1186/s12933-015-0294-0

Fig. 1.

Fig. 1

Schematic depiction of the main biochemical and clinical effects of DPP4 (dipeptidyl peptidase-4) inhibition. While both the increasing (green arrows) and decreasing (blue arrows) effects seem to be favorable, the overall influence on MACE (major adverse cardiovascular events) remains uncertain